EVALUATION OF THE EFFICACY AND SAFETY OF DOMESTIC GONADOTROPIN RELEASING HORMONE ANALOGUE IN THE TREATMENT OF GIRLS WITH IDIOPATHIC CENTRAL PRECOCIOUS PUBERTY

• In: Poster Session
• At: Düsseldorf (Germany) (2015)
• Type: Poster
• By: HUANG, Juyi (Cathay Medical Care Corporate Sijhih Cathay General Hospital, New Taipei City, China Taiwan)
• Co-author(s): Ju-yi Huang
  
• Abstract:

  Leuprorelin is subcutaneously administered once every 4 weeks for the suppression of gonadotropic activation and delaying epiphyseal closure in children.

  We retrospectively reviewed the hospital medical records with ICD-9:2591 from Aug 2007 to Dec 2014. All subjects were treated with Leuprorelin at least 1 year. After a year of GnRH agonist

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login